Medicared For All Logo

Mouhammed Rihawi MD in Milwaukee, Wisconsin

Home Wisconsin Milwaukee

Mouhammed Rihawi MD has Pulmonary Disease as his primary medical specialty. Their primary office is: 2900 W Oklahoma Ave in Milwaukee, Wisconsin.

They're a part of the: Rihawi Md Sc medical group which has around 3 members. You can call their office at 414-649-5288 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1993 (around 31 years of experience). They are listed as doing telehealth appointments.


Mouhammed Rihawi MD Office Phone and Directions

Mouhammed Rihawi MD
Rihawi Md Sc
2900 W Oklahoma Ave
Milwaukee, Wisconsin 53215
414-649-5288


Patient Ratings
Please rate your experience with Mouhammed Rihawi MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 414-649-5288


Enter a starting address:


Healthcare Info for Mouhammed Rihawi MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1993
The Primary Medical Specialty for Mouhammed Rihawi MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 31
PAC (PECOS ID)#: 4587559273
NPI #: 1972542348
NPI Created On: 06/04/2006
NPI Last Updated Listed as: 11/06/2008
Primary Taxonomy Code: 207RP1001X
License Number:
40232-020
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Dean Health Plan
  • Molina Healthcare of Wisconsin, Inc.
  • Aspirus Arise Health Plan of Wisconsin, Inc.
  • Network Health Plan
  • Children's Community Health Plan
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Arabic, ENGLISH, ARABIC.


Services and Procedures include:

  1. Irrigation and suction of lung airways to obtain cells using an endoscope
  2. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
  3. Test for exercise-induced lung stress
  4. Initiation and management of continued pressured respiratory assistance by mask or breathing tube
  5. Determination of lung volumes using plethysmography
  6. Measurement of lung diffusing capacity
  7. Sleep monitoring of patient (6 years or older) in sleep lab
  8. Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube
  9. New patient office or other outpatient visit, typically 60 minutes
  10. Established patient office or other outpatient visit, typically 15 minutes
  11. Established patient office or other outpatient, visit typically 25 minutes
  12. Established patient office or other outpatient, visit typically 25 minutes
  13. Established patient office or other outpatient, visit typically 40 minutes
  14. Initial hospital inpatient care, typically 70 minutes per day
  15. Subsequent hospital inpatient care, typically 15 minutes per day
  16. Subsequent hospital inpatient care, typically 25 minutes per day
  17. Subsequent hospital inpatient care, typically 35 minutes per day
  18. Subsequent nursing facility visit, typically 15 minutes per day
  19. Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes
  20. Physician telephone patient service, 5-10 minutes of medical discussion

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $1

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801747290

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $1,200

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 801750309

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $1,200

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 801752895

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $3,600

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 801754565

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802056229

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802076295

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802140777

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: ANORO ELLIPTA

Open Associated Drug #1: 0173-0869-06


Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802231051

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802437815

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802476405

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Pulmonary Disease Professionals in Milwaukee

3237 S 16th St
Milwaukee, WI
Independent Physicians Of Wisconsin Llc

5434 W Capitol Dr
Milwaukee, WI
Independent Physicians Of Wisconsin Llc

945 N 12th St
Milwaukee, WI
Independent Physicians Of Wisconsin Llc

2500 W Layton Ave
Milwaukee, WI
Independent Physicians Of Wisconsin Llc

9200 W Wisconsin Ave
Milwaukee, WI
The Medical College Of Wisconsin Inc

8701 W Watertown Plank Rd
Milwaukee, WI
The Medical College Of Wisconsin Inc

Providers in Rihawi Md Sc

1.Thomas Freichels

2900 W Oklahoma Ave
Milwaukee Wi 53215-4330
Rihawi Md Sc
Nurse Practitioner

2.Angela Monzon Np

2900 W Oklahoma Ave
Milwaukee Wi 53215-4330
Rihawi Md Sc
Nurse Practitioner

3.Mouhammed Rihawi Md

2900 W Oklahoma Ave
Milwaukee Wi 53215-4330
Rihawi Md Sc
Pulmonary Disease

View all 3 members of Rihawi Md Sc medical group